Island Pharmaceuticals Ltd has released a press release.
Successful Phase 2 clinical trial of ISLA-101
Filed with ASX ·
6ix hasn’t read this filing yet.
Island Pharmaceuticals Ltd on 6ix
Earlier from Island Pharmaceuticals
- Island completes $3.6 million placement
- Quarterly Activities & Cashflow Report
- Phase 2a/b clinical trial update
- Completion of patient dosing in Phase 2b clinical trial
- Completion of enrolment in Phase 2b arm
Later from Island Pharmaceuticals
- Portfolio expansion achieved with acquisition of Galidesivir
- Completion of Galidesivir transaction
- Options exercise from existing substantial shareholder
- Preliminary Final Report
- FDA meeting request lodged for Galidesivir
Follow Island Pharmaceuticals into a list and get an email when it puts out news.
Follow Island Pharmaceuticals